FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/16/2026
Back to search
Official data from USPTO
SOLVONIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SOLVONIS
ST13
US500000079422293Class
1, 5, 42, 44
Filing
79422293
Registration
8140050
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/16/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
12/06/2024
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
08/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
84
Owner location
GB
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Solvonis Therapeutics plc
Graft Polymer (UK) Plc
Representatives
William C. Wright Epstein Drangel LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and chemical substances for use in industryin science and chemical preparations for use in the manufacture of pharmaceuticals; biological and biochemical substances being organic chemical compoundssynthetic chemical compoundsenzymesnucleic acidsnon-medical chemical reagentsbiochemical catalysts and non-medical diagnostic reagents for use in industry and sciencepeptide substrates for scientific purposesproteins for use in manufacturechemical solvents for use in the manufacture of pharmaceuticalssmall molecule chemical compounds and chemical intermediates for use in the manufacture of pharmaceuticals
Class 5
Pharmaceuticals and medical preparations being chemical intermediatesbeing chemical diagnostic preparations for medical purposes and being chemical preparationssmall molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of neurodegenerative diseasesmovement disordersneurodevelopmental disordersneurological disordersconditions and diseases and of central nervous system disordersconditions and diseases; pharmaceuticals and medical preparations being chemical preparations and small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of behavioural health disordersmental health disorders and addiction
Class 42
Scientific laboratory services; clinical research servicesconducting clinical trials for others; scientific advisoryscientific analysisassessment being quality control for othersassistance being technical support for others being testing and evaluation of clinicallaboratory and medical equipment and software to improve performance and efficiency of such equipment and softwaretroubleshooting in the nature of diagnosing problems with clinicallaboratory and medical equipment and softwareauditing being quality control for othersconsultancydesigndevelopmentdue diligence being quality control for othersquality evaluationscientific informationinspection being quality control for othersresearch and testing services in the fields of chemicalsof chemical substancesof biological substancesof biochemical substancesof scienceof clinical researchof artificial intelligenceof machine learning and of biotechnology; scientific analysisassessment being quality control for othersassistance being technical support for others being testing and evaluation of clinicallaboratory and medical equipment and software to improve performance and efficiency of such equipment and softwaretroubleshooting in the nature of diagnosing problems with clinicallaboratory and medical equipment and softwareauditing being quality control for othersdesigndevelopmentdue diligence being quality control for othersquality evaluationinspection being quality control for othersresearch and testing services in the fields of medicineof pharmaceuticalsof medical diagnosticsof biomarkers and of bioinformatics; auditing being quality control for othersdesigndevelopmentdue diligence being quality control for othersinspection being quality control for others and research services in the fields of chemicalschemical substancesbiological substancesbiochemical substances and pharmaceuticals for therapyof telehealthof mental healthof medical counsellingof psychologyof psychotherapyof health counsellingof behavioural health counsellingof behavioural healthof behaviour and of addiction
Class 44
Medical services; pharmaceutical compounding services; cognitivebehaviouralcentral nervous systemneurologicalphysicalpsycho-social and mental health therapy services; cognitivebehaviouralcentral nervous systemneurologicalphysicalpsycho-social and mental health telehealth services; mental health services; medical counselling services; psychological counselling services; psychotherapy services; health counselling services; behavioural health counselling services; health care servicesnamely design and provision of behavioural health treatment programmes; health care servicesnamely addiction counselling and treatment services; medical servicesnamely administrationadvisoryanalysisassessmentassistanceconsultancyevaluationinformation and testing services in the fields of cognitivebehaviouralcentral nervous systemneurologicalphysicalpsycho-social and mental health therapyof telehealthof mental healthof medical counsellingof psychologyof psychotherapyof health counsellingof behavioural health counsellingof behavioural healthof behaviour and of addiction; medical advisoryconsultancy and information services in the fields of medicineof pharmaceuticalsof medical diagnosticsof biomarkers and of bioinformatics
Publications
History of USPTO decisions and trademark events.
26 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/16/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/17/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2025
PUBO
PUBLISHED FOR OPPOSITION
12/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/16/2025
RFNT
REFUSAL PROCESSED BY IB
08/16/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/26/2025
RFRR
REFUSAL PROCESSED BY MPU
07/26/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/03/2025
CNRT
NON-FINAL ACTION WRITTEN
06/02/2025
DOCK
ASSIGNED TO EXAMINER
05/27/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/16/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/25/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens SOLVONIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.